About MicroPort CardioFlow Medtech Corporation
MicroPort CardioFlow Medtech Corporation is a company based in Pudong (China) founded in 2015. MicroPort CardioFlow Medtech Corporation has raised $132.02 million across 4 funding rounds from investors including CICC, SDIC and Lake Bleu Capital. The company has 430 employees as of December 31, 2024. MicroPort CardioFlow Medtech Corporation operates in a competitive market with competitors including Shockwave Medical, Venus MedTech, Cardiac Dimensions, Pi-Cardia and Peijia Medical Technologies, among others.
- Headquarter Pudong, China
- Employees 430 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
$50.48 M (USD)5.52as on Dec 31, 2024
-
Net Profit
-$6.9 M (USD)89.71as on Dec 31, 2024
-
EBITDA
-$5.21 M (USD)83.88as on Dec 31, 2024
-
Total Equity Funding
$132.02 M (USD)
in 4 rounds
-
Latest Funding Round
$130 M (USD), Series C
Apr 15, 2020
-
Investors
CICC
& 8 more
-
Employee Count
430
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of MicroPort CardioFlow Medtech Corporation
MicroPort CardioFlow Medtech Corporation is a publicly listed company on the HKEX with ticker symbol 2160 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of MicroPort CardioFlow Medtech Corporation
MicroPort CardioFlow Medtech Corporation has successfully raised a total of $132.02M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $130 million completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MicroPort CardioFlow Medtech Corporation
MicroPort CardioFlow Medtech Corporation has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include CICC, SDIC and Lake Bleu Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Acquisitions are targeted by CPE as a private equity firm.
|
Locked | Locked | Locked | |
|
Private equity fund focused on multiple sectors
|
Locked | Locked | Locked |
Investor details for MicroPort CardioFlow Medtech Corporation
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MicroPort CardioFlow Medtech Corporation
Investment portfolio details for MicroPort CardioFlow Medtech Corporation
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MicroPort CardioFlow Medtech Corporation
Detailed financials for MicroPort CardioFlow Medtech Corporation
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Microport Cardioflow Medtech Corporation Comparisons
Peer comparison for MicroPort CardioFlow Medtech Corporation
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MicroPort CardioFlow Medtech Corporation
MicroPort CardioFlow Medtech Corporation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Shockwave Medical, Venus MedTech, Cardiac Dimensions, Pi-Cardia and Peijia Medical Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed.
|
|
| Locked | Locked | Locked |
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures.
|
|
| Locked | Locked | Locked |
Invasive cardiac implants for heart failure treatment are developed.
|
|
| Locked | Locked | Locked |
Non-implant devices for cardiac valve repair are developed and manufactured.
|
|
| Locked | Locked | Locked |
Medical devices for cardiac and cerebrovascular treatments are developed.
|
Detailed competitors of MicroPort CardioFlow Medtech Corporation
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Microport Cardioflow Medtech Corporation
Complete news archive for MicroPort CardioFlow Medtech Corporation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MicroPort CardioFlow Medtech Corporation
MicroPort CardioFlow Medtech Corporation was founded in 2015 and raised its 1st funding round 1 year after it was founded.
MicroPort CardioFlow Medtech Corporation is headquartered in Pudong, China. It is registered at Pudong, Shanghai, China.
MicroPort CardioFlow Medtech Corporation is a funded company, having raised a total of $132.02M across 4 funding rounds to date.
As of Dec 31, 2024, the latest employee count at MicroPort CardioFlow Medtech Corporation is 430.
Annual revenue of MicroPort CardioFlow Medtech Corporation is $50.48M as on Dec 31, 2024.
Founded in 2015 and based in Pudong, China, the company operates in the medtech sector with a focus on devices for heart valve conditions. Transcatheter aortic valve implantation products, such as VitaFlow for treating aortic stenosis in elderly patients, are provided. Additional offerings include the Alwide Aoguang valve balloon dilation catheter for surgical aortic valve replacement and the Alpass Ao Shun catheter sheath kit, among others.
MicroPort CardioFlow Medtech Corporation's top competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.
Yes, MicroPort CardioFlow Medtech Corporation is publicly traded on HKEX under the ticker symbol 2160.
MicroPort CardioFlow Medtech Corporation has 9 investors. Key investors include CICC, SDIC, Lake Bleu Capital, CPE, and CDG Capital.
The ticker symbol of MicroPort CardioFlow Medtech Corporation is 2160 on HKEX.
The valuation of MicroPort CardioFlow Medtech Corporation is $2.02M as of Aug 2016.